Literature DB >> 23347329

Losing a job on purpose: relationships with borderline personality symptomatology.

Randy A Sansone1, Michael W Wiederman.   

Abstract

AIM: The purpose of the present study was to examine one facet of employment viability, losing a job on purpose, among individuals with borderline personality symptomatology (BPS).
METHODS: Using a cross-sectional self-report survey methodology in a combined sample of four prior studies from the same study site (n = 1493), we examined the relationship between losing a job on purpose and two self-report measures for BPS.
RESULTS: There were 7.6% of participants that endorsed losing a job on purpose, with no statistically significant difference between the proportions of males and females. Point-biserial correlation coefficients revealed that those who endorsed losing a job on purpose scored statistically significantly higher on both measures of BPS and were more likely to exceed the clinical cut-off scores on both measures of BPS. Multiple regression analyses indicated that findings were independent of gender or age.
CONCLUSION: One factor in poor employment viability among individuals with BPS appears to be the behaviour of losing a job on purpose.
© 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23347329     DOI: 10.1111/eip.12014

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  2 in total

1.  Comparison of Objective and Subjective Life Balance Between Women With and Without a Personality Disorder.

Authors:  Nadine Larivière; Catherine Denis; Amélie Payeur; Amélie Ferron; Stéphanie Levesque; Guillaume Rivard
Journal:  Psychiatr Q       Date:  2016-12

2.  The impact of bipolar spectrum disorders on professional functioning: A systematic review.

Authors:  Monika Dominiak; Piotr Jażdżyk; Anna Z Antosik-Wójcińska; Magdalena Konopko; Przemysław Bieńkowski; Łukasz Świȩcicki; Halina Sienkiewicz-Jarosz
Journal:  Front Psychiatry       Date:  2022-08-24       Impact factor: 5.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.